Loading...
A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
BACKGROUND: Buprenorphine treatment is not equally effective in all patients with opioid use disorder (OUD). Two retrospective studies showed that, among African Americans (AAs), rs678849, a polymorphism in the delta-opioid receptor gene, moderated the therapeutic effect of sublingual buprenorphine....
Na minha lista:
| Udgivet i: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883889/ https://ncbi.nlm.nih.gov/pubmed/32920647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyaa069 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|